Skip to main content
Day.News — Local News. Real Community.
COLUMBUS DAY NEWS
Local News. Real Community.
health
1 min read

Planned Parenthood Clinics in Two States to Offer Advance Supply of Abortion Pills

Planned Parenthood clinics in Washington state and Hawaii will now provide patients with abortion pills in advance. The pills, mifepristone and misoprostol, can be stored for future use if a patient chooses to terminate a pregnancy.

06/12/2026 · Minnesota edition

Advertisement

Advertisement

Planned Parenthood clinics in Washington state and Hawaii will begin offering patients a supply of mifepristone and misoprostol to keep on hand. These medications are used to medically terminate pregnancies.

Patients can obtain the pills during a regular consultation with a Planned Parenthood health care provider. If the patient later experiences an unwanted pregnancy, they can then use the medication without requiring an immediate appointment.

Planned Parenthood representatives stated the new service aims to improve access to reproductive healthcare. The organization has not yet released details about cost or specific eligibility requirements.

Related Topics

Editorial Transparency
AI-Generated · Written by National Desk

Article Ratings

Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0

How do you feel about this story?

NA

National Desk

Trust 3.1104047 articles8,231,170 views75% fact accuracy
View Profile

Sign in to follow this author from their profile.

Discussion (0)

Join the Conversation

Join the conversation

Sign in to share your thoughts, reply to readers, and like comments.

Sign in to comment
Sort by:
0 comments

No comments yet. Be the first to comment!

Trending Now

Trending stories will appear here.

More from Minnesota

No other local stories are available right now.

Events & Things to Do

Read section →

Upcoming events will appear here.

Advertisement

Advertisement

Keep Reading

Related Stories

More health stories from Minnesota

health

Transgender Inmates Challenge Federal Prison Policy on Healthcare Access

Attorneys representing transgender inmates have urged the Supreme Court to maintain a lower court's order. This order currently blocks the Federal Bureau of Prisons from enforcing a new policy restricting healthcare and social accommodations for transgender prisoners. The policy, implemented by the Trump administration, eliminates access to hormone therapy and items like makeup and wigs.

Read Story →
health

Government Review Examines Diagnoses of ADHD and Autism in Young People

A recent government review focused on younger individuals and their diagnoses of ADHD and autism. The report highlighted a shift in diagnostic patterns over time. Officials involved in the review acknowledged evolving societal and clinical approaches.

Read Story →
health

Family Calls for Allergy Management Ratings After Child's Death

The family of Mia St Hilaire, a 12-year-old who died after an anaphylactic reaction, now advocates for improved allergy management ratings. Mia consumed a milkshake that triggered her tree nut allergy.

Read Story →
health

Discussion Addresses Mental Health, Suicide Trends in Black Community

NPR's Michel Martin hosted a panel discussion on mental health and suicide within the Black community. The conversation explored the subject through personal perspectives. Participants shared individual experiences.

Read Story →
health

FDA to Conclude Abortion Pill Safety Review by March

The Food and Drug Administration (FDA) will finalize its safety review of mifepristone in March. A Louisiana federal judge mandated this update as part of a legal challenge seeking to reverse a policy allowing mail delivery of the abortion medication.

Read Story →
health

GLP-1 Medications Show Potential in Addressing Addiction

New evidence suggests GLP-1 drugs, commonly used for diabetes and weight loss, may also reduce cravings for addictive substances. Scientists are conducting studies to determine if these medications can help individuals with substance use disorders. This research explores a potential new application for GLP-1s in public health.

Read Story →
Scroll for more stories